825 million shares, $70 to $78 apiece. Multiply, and the public tranche tops out at $64.35 billion.
That is the ceiling on the offering, per the prospectus updated on November 10. Pricing lands on the 18th, the Nasdaq debut on the 19th under the ticker ANT. A $26 billion private placement runs alongside, for a maximum of $90.4 billion.
Three numbers, side by side.
Public raise: $64.35 billion. Compute commitments due within 12 months: $70.7 billion. The difference is negative $6.35 billion. A small gap that sets the tone: the company is not selling profit, but a signed compute contract and a revenue curve in motion. The first use of proceeds is to pay a bill.
Two valuations, 4.9 billion shares apart
$1.26 trillion to $1.41 trillion is the fully diluted valuation implied by the range. Nearly every retelling drops the words "fully diluted."
Divide $1.405 trillion by $78: 18 billion shares. At $78 the company is worth about $1.02 trillion, which divided by $78 gives 13.1 billion. The two counts differ by 4.9 billion shares.
Those are not new issue: employee options, restricted stock, charitable matching reserves, all already on the books. Whether they sit in the denominator decides whether this is a $1.02 trillion company or a $1.405 trillion one — a $385 billion spread.
So the first question is not whether a trillion-dollar valuation is expensive, but how deep the denominator goes.
A $104 billion loss that is not a loss
First nine months of 2026: revenue $33.242 billion, up 1,206%; the third quarter brought $16.956 billion. Net loss was $104.039 billion, operating loss $1.260 billion. The two differ by $102.8 billion, three times nine-month revenue.
None of it sits in operations.
It paid no cash. It re-marked convertible notes issued in earlier years against the latest valuation. Convertible instruments, derivative liabilities and SAFEs are remeasured each period: a rising valuation lifts the liability, and the difference runs through the income statement.
Read it backwards: the loss is a by-product of a rising valuation, not evidence of failure.
Net losses ran $1.5 billion, $8.3 billion and $42 billion across 2023 to 2025, a 28-fold increase. Of the $33.242 billion, usage-based billing was $26.306 billion, or 79.1%; subscriptions $6.936 billion.
Four-fifths of revenue settles by usage, tying cash flow to how often customers call the model, not to contract length. That is what lets Anthropic commit $900.9 billion. It cuts both ways: if usage slows, confidence drains faster than the contracts, which are take-or-pay.
The $900.9 billion compute ledger
As of September 30, 2026, purchase commitments and lease obligations total roughly $900.9 billion, mostly compute and infrastructure. $451.6 billion falls due by 2030, $70.7 billion within 12 months, the rest by 2045. Another $213.8 billion carries termination rights or preconditions — financing closed, facilities ready, regulators approving.
Divide by annualized revenue near $44.3 billion: 20.3 times.
Two decades of future revenue, signed away as compute contracts.
Compute and infrastructure spending for the nine months was $18.808 billion, up 329%, or 56.6% of revenue. The third quarter alone was $9.863 billion, 58% of revenue. Management credited $5 billion of new short-term compute purchases and $2 billion of non-cash charitable matching expense.
$146.7 billion in the bank, and still raising
Back to the subtraction. The raise covers $64.35 billion of a $70.7 billion bill; the placement closes the rest. Seven buyers fund it: Google, Microsoft, Nvidia, AMD, Broadcom, Micron and TSMC, taking Class N common stock at the same price.
The loop closes tightly: the companies selling it chips are buying its stock, and it uses the proceeds to pay its compute bill.
Cash is not the problem: $146.7 billion across cash, short-term investments and credit at September 30, enough on its own. So why raise? Because $451.6 billion must be paid by 2030, and the schedule runs to 2045. The IPO is not a rescue. It is fuel.
4.6% of the float, 28% of the bid
825 million shares divided by 18 billion is 4.6%.
The deal sells 4.6% of the company. Retail is targeted near 20%, two to four times a conventional IPO. According to press reports, the book was about six times covered by November 12.
Then the index layer. Market institutions estimate Anthropic could enter at least six indices within 5 to 15 days of listing, with passive demand near 28% of the shares offered — roughly $19 billion that reads weight, not valuation.
When it rises, index funds must buy. When it falls, those funds have no obligation to catch it.
A range is not a price
$70 to $78 is a range, not a price.
The number can land at the floor, the midpoint or the top, and the syndicate can move it on the last day — routine, not accident. At $74 the fully diluted valuation is about $1.33 trillion; at $70, $1.26 trillion.
The May private round priced the company at $965 billion. Six months later it is up 30% to 46%, while quarter-on-quarter revenue growth fell from 144% to 47%.
The range caps at $78, about 30% below the $2 trillion target circulating inside banks over the summer.
Four lines worth reading
Commitments: $900.9 billion, $70.7 billion due within a year, $213.8 billion conditional.
Net loss: of $104.039 billion, $102.8 billion is non-operating.
Shares: 18 billion fully diluted, 13.1 billion basic.
Compute spending: $18.808 billion, 56.6% of revenue.
Together they describe one trade. Two decades of compute contracts bought this year's revenue growth. A mark-to-market revaluation bought a headline loss. A 4.6% float bought a flattering opening print. None of it is fraud.
On the 19th, the number flashing on the screen is market cap.
The $70.7 billion in the S-1 will not flash.
*Disclaimer: This article is based on publicly available information and is for reference only. It does not constitute investment advice.*
